深圳赛格股份有限公司2024年第三季度报告(英文版)

Third Quarterly Report for 2024, Shenzhen SEG Co., Ltd. 1 Stock code: 000058, 200058 Stock abbreviation: SHEN SEG , SHEN SEG B Notice No.: 2024-052 Shenzhen SEG Co., Ltd. The Third Quarterly Report for 2024 The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate and complete, and there are no false records, misleading statements or material omissions. Important Notice: 1. The Board of Directors, the Board of Supervisors, Directors, Supervisors and senior management guarantee that the quarterly report is true, accurate and complete, without any false records, misleading statements or material omissions, and that they assume individual and joint legal responsibility. 2. The person in charge of the Company, head of accounting work and head of accounting institution (accounting officer in charge) declare that they guarantee the truthfulness, accuracy and completeness of the financial information in the quarterly report. 3. Whether the Third Quarterly Report has been audited □ Yes No Third Quarterly Report for 2024, Shenzhen SEG Co., Ltd. 2 I. Main Financial Data (I) Main accounting data and financial indicators Whether the Company needs to perform retrospective adjustment or restatement of accounting data for the previous years □ Yes No Current period Changes over the same period of the previous year Beginning of the year to end of the current period Changes over the same period of the previous year Operating income (RMB) 441,574,388.36 -0.09% 1,243,637,571.71 -9.98% Net profit attributable to shareholders of the listed company (RMB) -12,803,265.02 -636.00% 38,126,457.05 -72.91% Net profit attributable to shareholders of the listed company after deducting non-recurring profit and loss (RMB) -11,396,664.68 -718.12% 41,364,068.32 -37.85% Net cash flow from operating activities (RMB) —— —— 56,115,225.68 -38.65% Basic earnings per share (RMB/share) -0.0104 -647.37% 0.0310 -72.88% Diluted earnings per share (RMB/share) -0.0104 -647.37% 0.0310 -72.88% Weighted average ROE -0.61% -0.74% 1.90% -5.16% End of the current period End of the previous year Changes over end of the previous year Total assets (RMB) 5,070,950,787.59 5,380,146,949.27 -5.75% Owner's equity attributable to shareholders of the listed company (RMB) 2,007,241,443.00 2,006,490,243.66 0.04% (II) Non-recurring items and amounts Applicable □ Not applicable Unit: RMB Item Amount of the current period Amount from beginning of the year to end of the current period Description Profits or losses from the disposal of non-current assets (including the write-off that accrued for impairment of assets) -2,532.52 -109,380.06 Governmental subsidies included in the current profits 454,413.15 1,359,245.39 Third Quarterly Report for 2024, Shenzhen SEG Co., Ltd. 3 and losses (the subsidies that are closely related to the Company's normal operating business, that conform to the national policies and are enjoyed in accordan

立即下载
综合
2024-10-30
15页
0.61M
收藏
分享

深圳赛格股份有限公司2024年第三季度报告(英文版),点击即可下载。报告格式为PDF,大小0.61M,页数15页,欢迎下载。

本报告共15页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
本报告共15页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
水滴研报所有报告均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
相关图表
图 10 样本创新药年涨跌幅度(%)
综合
2024-10-29
来源:创新药行业周报:国谈启动,关注相关品种纳入医保放量投资机会
查看原文
图 7 样本创新药周涨幅 TOP10(%) 图 8 样本创新药周跌幅 TOP10(%)
综合
2024-10-29
来源:创新药行业周报:国谈启动,关注相关品种纳入医保放量投资机会
查看原文
图 5 美国十年期国债收益率(%) 图 6 近期美国十年期国债收益率(%)
综合
2024-10-29
来源:创新药行业周报:国谈启动,关注相关品种纳入医保放量投资机会
查看原文
图 3 国内生物科技指数 PB 图 4 恒生生物科技指数 PB
综合
2024-10-29
来源:创新药行业周报:国谈启动,关注相关品种纳入医保放量投资机会
查看原文
图 1 国内外主要市场生科指数周涨跌幅(%) 图 2 全球主要生物科技指数近一年走势
综合
2024-10-29
来源:创新药行业周报:国谈启动,关注相关品种纳入医保放量投资机会
查看原文
环保行业重点推荐组合基本数据一览
综合
2024-10-29
来源:环保行业周报:完善碳排放统计核算体系工作方案出台,奠定全国范围碳排放双控基础
查看原文
回顶部
报告群
公众号
小程序
在线客服
收起